Login to Your Account

Other News To Note

Wednesday, July 20, 2011
Siena Biotech SpA, of Siena, Italy, received an undisclosed milestone payment from Roche AG, of Basel, Switzerland, stemming from the firms' 2007 neurodegenerative disease collaboration. Roche exercised its option last year to take the lead on developing and commercializing selected molecules for treating Alzheimer's disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription